Change in quality of life of patients undergoing silicone stent intubation for nasolacrimal duct stenosis combined with dry eye syndrome

2015 ◽  
Vol 99 (11) ◽  
pp. 1519-1522 ◽  
Author(s):  
Jong Rok Oh ◽  
Jee Ho Chang ◽  
Jin Sook Yoon ◽  
Sun Young Jang
2009 ◽  
Vol 19 (4) ◽  
pp. 572-579 ◽  
Author(s):  
Gemma Caterina Maria Rossi ◽  
Carmine Tinelli ◽  
Gian Maria Pasinetti ◽  
Giovanni Milano ◽  
Paolo Emilio Bianchi

Purpose To verify the presence of dry eye syndrome (DES) in treated patients with glaucoma and to analyze DES's impact on the patients' quality of life (QOL) versus the control group. Methods In this observational cross-sectional study, 61 patients were enrolled at a clinical practice. Patients were divided into three groups by number of glaucoma drops instilled per day (G1=1 drop/day, G2=2 drops/day, G3=3 drops/day). A control group of 20 subjects was also selected (G0). All subjects were submitted to a complete ocular examination (including tear function and ocular surface status) and completed the 25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ), Glaucoma Symptom Scale (GSS) questionnaire, and Ocular Surface Disease Index (OSDI). DES was defined as presence of punctate keratitis and decreased break-up time. Statistical analysis was performed applying the Kruskal-Wallis analysis of variance and Mann-Whitney U tests (to compare median values between groups) as well as the χ2 and Fisher test (to verify significant differences). Results A total of 40% of G3 and 39% of G2 patients presented DES versus 11% of G1 and 5% of G0 (p=0.01). QOL was significantly influenced and altered (NEI-VFQ 25 total mean and GSS total mean and symptoms average: p=0.0085, p=0.006, and p=0.03, respectively). OSDI pointed out differences by group: 26% of G2 and 15% of G3 presented moderate OSDI and 15% of G3 and 8.7% of G2 severe OSDI (p>0.05). Conclusions Patients with topically treated glaucoma present DES more often than a similar control group (p=0.01). The presence of DES negatively influences the patient's QOL. The patients with glaucoma's ocular surface status should be evaluated regularly to ensure the timely detection and treatment of pathologic signs on the ocular surface.


2013 ◽  
Vol 92 (2) ◽  
pp. e124-e132 ◽  
Author(s):  
Qihua Le ◽  
Ling Ge ◽  
Meiyan Li ◽  
Liangcheng Wu ◽  
Jianjiang Xu ◽  
...  

2007 ◽  
Vol 143 (3) ◽  
pp. 409-415.e2 ◽  
Author(s):  
Biljana Miljanović ◽  
Reza Dana ◽  
David A. Sullivan ◽  
Debra A. Schaumberg

2005 ◽  
Vol 6 (3) ◽  
pp. 185-196
Author(s):  
Lorenzo Pradelli ◽  
Letizia Vacchini

BACKGROUND: The dry eye sindrome refers to a group of disorders of the tear film due to reduced tear production or excessive tear evaporation that is associated with symptoms of ocular discomfort and may cause disease of the ocular surface. Dry eye syndrome varies in severity, duration and etiology. The cornerstone of dry eye syndrome therapies includes the intraocular gel or ophthalmic solutions instillation, reaching correct artificial lubrication. Molecules that can produce a stable lubricating film are the carbomers. METHODS: In the first step of our work we reviewed the data from literature reporting about carbomers’ characteristics in respect to other lacrimal substitutes. Then, a pharmacoeconomical analysis has been performed on ophtalmic gels derived from carbomers 974P and PVA. RESULTS: Dry eye sindrome, if not adequately treated, determines a deterioration of the patient’s quality of life, other than high secondary costs. CONCLUSION: The high therapeutical index of carbomers 974P and PVA-based gels, in addition to the their limited cost (totally free for Sjögren patients in Italy), suggests that this product is characterized by one of the best benefits-to-costs ratios in the treatment of dry eye sindrome.


2018 ◽  
Vol 15 (2) ◽  
pp. 151-159
Author(s):  
V. N. Trubilin ◽  
E. G. Poluninа ◽  
D. V. Andzhelova ◽  
Yu. V. Evstigneeva ◽  
K. V. Chinenova

Pregnant women are objects of special medical attention due to the fact that the new life — the life of her child — depends on the health  and quality of life of the future mother. Pregnancy is a physiological  load. It makes temporary changes in the functional state of all  organs and systems, including the organ of vision. This study was  aimed at identifying risk factors for the occurrence of disturbances in the tear-producing system — dysfunction of the Meibomian glands  and/or dry eye syndrome (SSH), as well as to develop recommendations for compensating of disturbance. The  study showed that physiological pregnancy does not affect to the  condition of the ocular surface in case of absence of dry eye  syndrome manifestations and Meibomian gland dysfunction before  pregnancy. However, there is a predisposition for the development of the symptom complex of dry eye syndrome — a reliable decrease  Schirmer test indicators of the test of in the group of pregnant  women, it requires preventive control, — reduction in the mode of  wearing contact lenses, which are a risk factor for the development  of dry eye syndrome. It was determined that in vitro fertilization  (IVF) affects to the condition of the ocular surface, namely, on the  occurrence of dysfunction of Meibomian glands and dry eye  syndrome, and is accompanied by corresponding complaints. There  is a direct correlation between the duration of gestation, age  indicators, the severity of complaints and their relationship to  pregnancy. A direct was established, with a noticeable tightness of  communication, between taking thyrotrophic drugs and complaints  on dryness and discomfort. Therefore, special attention should be  given to pregnant patients taking thyrotrophic medications and using contact lenses, since both of these factors provoke the development  of the dry eye symptom complex. Patients with IVF pregnancy and  accompanied by taking thyrotrophic drugs are recommended to limit  the mode of wearing contact lenses, in case of complaints on  dryness, discomfort, it is necessary to conduct therapeutic and  prophylactic effects in the form of non-conserved tear-replacement  therapy and eyelid hygiene. Timely diagnosis and subsequent  prevention of Meibomian glands and dry eye syndrome in pregnant  women will improve the quality of life of this patients group and  prevent the development of complications related to this condition.


2021 ◽  
Vol 18 (4) ◽  
pp. 938-945
Author(s):  
D. Yu. Maychuk ◽  
A. O. Loshkareva ◽  
A. A. Tarkhanova

Currently the ophthalmologists meet with corneal-conjunctival xerosis more often in their daily practice. The objective of this research is identifying a new alternative method of treatment of the dry eye syndrome of different severity. In this work there will be a demonstration and the results of usage of BAA Delphanto® in treatment of different cases of the dry eye syndrome. The data collected from a dynamic research of groups of patients reveals the effectiveness of the comprehensive therapy with the use of BAA Delphanto®. Consequently, the research results demonstrate an improvement of the initial data from the biomicroscopy, OSDI index, Schirmer-1 test and the tear break up time. The statistically significant results were received reveal the effectiveness of the use of BAA Delphanto® with a significant improvement of the quality of life. It can be used widely by ophthalmologists for the treatment of corneal-conjunctival xerosis of different severity.


2020 ◽  
Vol 11 (3) ◽  
pp. 196-203
Author(s):  
Cristina Ariadna NICULA ◽  
◽  
Dorin NICULA ◽  
Gabriela DOGARU ◽  
Adriana Elena BULBOACĂ ◽  
...  

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Qihua Le ◽  
Xiaodong Zhou ◽  
Ling Ge ◽  
Liangcheng Wu ◽  
Jiaxu Hong ◽  
...  

Author(s):  
Zoya Veselovska ◽  
Nataliia Veselovska ◽  
I Zaporozhchenko

The work is dedicated to investigation of influence of medications SuperOpticTM Aqua and SuperOpticTM Complit on to the anterior eye surface in before and postoperation period in patients with phaco. Materials and methods. 28 patients (56 eyes) in age 59-80 were examined. In first group – patients with dry eye syndrome 1-2 st. (a, b: a – 14 eyes; b – 14 eyes) 2 weeks before the phaco and in postoperation period used SuperOpticTM Aqua in regimen 1 drop 2-3 times/day. In second group – patients with dry eye syndrome 3-4 st. (c – 14 eyes; d – 14 eyes) 2 weeks before the phaco and in postoperation period used SuperOpticTM Complit in regimen 1 drop 2-3 times/day. Results. In this investigation we revealed improvement the quality of life in patients in prevention and treatment dry eye syndrome who undergone phaco with help of SuperOpticTM Aqua and SuperOpticTM Complit depending of the stage of dry eye syndrome.


Sign in / Sign up

Export Citation Format

Share Document